Type B insulin resistance syndrome induced by anti-PD-1 therapy

J Diabetes. 2024 Sep;16(9):e13603. doi: 10.1111/1753-0407.13603.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Female
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects
  • Immune Checkpoint Inhibitors / therapeutic use
  • Insulin Resistance*
  • Male
  • Middle Aged
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors

Substances

  • Programmed Cell Death 1 Receptor
  • Immune Checkpoint Inhibitors
  • Antibodies, Monoclonal, Humanized